A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Celiprolol has been studied across 18 research domains including ❤️ Cardiovascular, 🔥 Metabolic, 🫁 Respiratory, ⚡ Energy & Fatigue, 🦴 Bone & Joint. The primary research focus is ❤️ Cardiovascular with 51% of studies addressing this area.
The following compounds share molecular targets with Celiprolol, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Celiprolol is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.